Columbia University Offers Soft Deadline for Pro-Hamas Students to Dismantle Their Encampm...
Alec Baldwin's Encounter With a Pro-Palestinian Activist Is a Warning to All
LIVE RESULTS: Pennsylvania Primary
Senators Deliver Message to Biden on Schools Allowing 'Pro-Terrorist Mobs'
CNN Once Again Delivers Media Malpractice From Gaza
Here's Who Trump Is Blaming for the Pro-Hamas Student Protests
Senate Passes Foreign Aid Package, Sending It to President Biden to Sign
Squad Member Summer Lee Survives Primary Challenge
There's Been an Update on Minnesota State Sen. Arrested for Burglary
Did Kristi Noem Complicate Her Chances for VP With This Sunday Show Abortion...
Biden's Crime Proclamation Sure Is Something
It's Been a Year Since the House Passed Rep. Greg Steube's Bill to...
Here's What Happened When a New York Homeowner Found Squatters on Her Property
Following Anti-Israel Protests, Columbia Switches to Hybrid Classes for the Rest of the...
Some of the Illegal Aliens DeSantis Sent to Martha’s Vineyard Will Be Permitted...
Tipsheet

Pfizer CEO: Our Vaccines Offer ‘Limited, If Any Protection’

AP Photo/Pablo Martinez Monsivais, File

Speaking during remarks to a J.P. Morgan healthcare conference this week, Pfizer CEO Albert Bourla openly stated current vaccines the company developed for Wuhan coronavirus offer "limited, if any" protection against contracting current variants of the disease. He then encouraged booster shots. 

The statement from Bourla comes as the Biden administration continues to justify vaccine mandates for federal workers, contractors and private businesses. The Supreme Court heard arguments about President Biden's mandates for private companies and medical workers last week. A ruling is expected soon on the constitutionality of the mandates. 

A number of people who have pointed out the waning efficacy of Pfizer's vaccines, which Bourla touted last year as being "100 percent" effective against contracting or transmitting the virus, have been banned by social media companies. 

Meanwhile, Bourla also announced this week the company is developing a vaccine specific to Omicron. It is expected to be ready in March when health officials predict the latest wave of the mild variant will already be over. 

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos